Lipid Metabolism, Epidemiology, and the Mechanisms of Alzheimer's Disease

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Annals of the New York Academy of Sciences

• Publication date

  2002-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1749-6632.2002.tb04842.xPMID 12480777
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Estrogen alters thresholds for B cell apoptosis and activation.

  2002cited by this paper
• Brain to Plasma Amyloid-β Efflux: a Measure of Brain Amyloid Burden in a Mouse Model of Alzheimer's Disease

  2002cited by this paper
• Patients with Alzheimer disease have lower levels of serum anti-amyloid peptide antibodies than healthy elderly individuals.

  2002cited by this paper
• Cholesterol and cognition: rationale for the AD cholesterol-lowering treatment trial and sex-related Differences in beta-amyloid accumulation in the brains of spontaneously hypercholesterolemic Watanabe rabbits.

  2002cited by this paper
• Serum lipoprotein levels, statin use, and cognitive function in older women.

  2002cited by this paper
• Prevalence of Alzheimer's type dementia in an elderly Arab population

  2001cited by this paper
• Incidence of Alzheimer’s disease in a rural community in India

  2001cited by this paper
• Peripheral anti-Aβ antibody alters CNS and plasma Aβ clearance and decreases brain Aβ burden in a mouse model of Alzheimer's disease

  2001cited by this paper
• Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer's disease.

  2001cited by this paper
• Role of apoe/Abeta interactions in the pathogenesis of Alzheimer's disease and cerebral amyloid angiopathy.

  2001cited by this paper
• Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier.

  2000cited by this paper
• Apolipoprotein E: far more than a lipid transport protein.

  2000cited by this paper
• β‐Amyloid Peptide Interacts Specifically with the Carboxyl‐Terminal Domain of Human Apolipoprotein E

  1999cited by this paper
• Interaction of transthyretin with amyloid beta-protein: binding and inhibition of amyloid formation.

  1996cited by this paper

• Infection, systemic inflammation, and Alzheimer's disease.

  2015cites this paper
• Proteomic analysis of the supernatant of red blood cell units: the effects of storage and leucoreduction

  2013cites this paper
• Biomarkers for Alzheimer's disease.

  2009cites this paper
• Reduced Membrane Lipids in the Cortex of Alzheimer’s Disease Transgenic Mice

  2008cites this paper
• Protease Inhibitors and their Involvement in Neurological Disorders

  2007cites this paper
• Neuronal Protein Trafficking in Alzheimer's Disease and Niemann-Pick Type C Disease

  2007cites this paper
• Neuroprotección por 2-(3,4 dihidroxifenil)etanol y ácidos grasos poliinsaturados omega-3 en modelos in vitro e in vivo

  2006cites this paper
• Comparative analysis of cortical gene expression in mouse models of Alzheimer's disease.

  2006cites this paper
• Microarray Analysis of the Effects of a γ-protein Kinase C Null Mutation on Gene Expression in Striatum: A Role for Transthyretin in Mutant Phenotypes

  2006cites this paper
• The acceptability of isoflavones as a treatment of menopausal symptoms: a European survey among postmenopausal women

  2005cites this paper
• The influence of smoking on plasma folate and lipoproteins in Alzheimer disease, mild cognitive impairment and depression.

  2005cites this paper